A-Fem Medical Corp. Receives Cash Infusion.PORTLAND, Ore.--(BW HealthWire)--Feb. 2, 1998--A-Fem Medical Corp. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. :AFEM AFEM Armed Forces Expeditionary Medal AFEM Air Force Emergency Management (US Air Force) ) today announced it had privately placed 390,625 shares of its common stock with an institutional investor Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. for proceeds of $750,000. The funds will be used to support the continuing expansion of its recently launched feminine protection product, the inSync(TM) miniform. The investor has also indicated plans to invest an additional $1,250,000 as the roll-out of inSync continues. "This investment resulted from our initial success in launching the inSync miniform," said Peter Burke Peter Burke (born 1937) is a British historian. He was educated by the Jesuits and at St John's College, Oxford, where he obtained his doctorate. From 1962 to 1979 he was part of the School of European Studies at Sussex University, before moving to the University of Cambridge where , president of A-Fem Medical Corp. "It illustrates the investment community's confidence in our products as well as our company," he added. The inSync miniform, an entirely new form of feminine protection, was launched in November 1997 throughout Washington and Oregon. The miniform is unique in that unlike a tampon tampon /tam·pon/ (tam´pon) [Fr.] a pack, pad, or plug made of cotton, sponge, or other material, variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. there is no insertion and unlike pads there are no adhesives. Measuring two inches long, the miniform is held in place naturally by a woman's body. "There is demand for the miniform in the marketplace. Our success in achieving distribution in all of the major regional retailers combined with the outstanding consumer response to our advertising campaign confirm this," stated Peter Burke. "These funds will support our continued regional roll-out of the inSync miniform. In line with plans, we will continue to use the success of our roll-outs to attract the funding necessary to complete national distribution," added Burke. A-Fem Medical Corporation is dedicated to developing innovative women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. care products. In addition to the miniform, A-Fem is developing point-of-care diagnostics providing quantification quan·ti·fy tr.v. quan·ti·fied, quan·ti·fy·ing, quan·ti·fies 1. To determine or express the quantity of. 2. of results based on its proprietary Rapid-Sense(TM) technology. For more information, visit the company's website at www.afem.com. -0- The discussion in this press release regarding A-Fem Medical Corporation ("Company") contains forward looking statements (as defined in Section 27A of the Securities Act of 1933, as amended) that involve risks and uncertainties, including the risks that the inSync miniform launch may not be successful, that the Company may not be able to attract the additional funding necessary to complete national distribution of the inSync miniform, that the Company's development stage products may not be successfully developed or if developed may not be marketable and other risks detailed from time to time in the Company's reports to the Securities and Exchange Commission, including the Company report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 1996. CONTACT: Burson-Marsteller Allyson Kovas, 415/764-1395 or A-Fem Medical Corporation Hilary Reinmuth, 503/968-8800 Ext. 17 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion